Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro by Robert Kleemann, Lars Verschuren, Bert-Jan de Rooij, Jan Lindeman, Moniek M. de Maat, Alexander J. Szalai, Hans M. G. Princen, and Teake Kooistra Blood Volume 103(11): June 1, 2004 ©2004 by American Society of Hematology
Effect of atorvastatin, simvastatin, fenofibrate, and Wy on plasma cholesterol and basal huCRP expression. Robert Kleemann et al. Blood 2004;103: ©2004 by American Society of Hematology
Induction of huCRP expression in huCRPtg mice. Robert Kleemann et al. Blood 2004;103: ©2004 by American Society of Hematology
Effect of atorvastatin, simvastatin, fenofibrate, and Wy on IL-1β-induced huCRP expression. Robert Kleemann et al. Blood 2004;103: ©2004 by American Society of Hematology
Statin treatment suppresses IL-1-induced huCRP gene expression in human liver cells. Robert Kleemann et al. Blood 2004;103: ©2004 by American Society of Hematology
Statin treatment inhibits NFκB activity. Robert Kleemann et al. Blood 2004;103: ©2004 by American Society of Hematology
Statin treatment reduces the nuclear amount of p50-NFκB ∼ C/EBPβ complexes. Robert Kleemann et al. Blood 2004;103: ©2004 by American Society of Hematology